Cara Therapeutics Inc (NASDAQ:CARA)

9.69
BATS BZX Real-Time Price
As of Oct 06
 0.00 / 0.00%
Today’s Change
7.40
Today|||52-Week Range
18.93
-20.44%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Cara Therapeutics Inc have a median target of 27.00, with a high estimate of 30.00 and a low estimate of 13.00. The median estimate represents a +178.64% increase from the last price of 9.69.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Cara Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.41
Sales
$9.8M
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -407.14%
 
 
 
 
 
 
Growthannually 28.74%
 
 
 
 
 
 

Sales

Growthquarterly -57.18%
 
 
 
 
 
 
Growthannually 161.91%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.